secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECT MEDICAL HOLDINGS CORP (SEM)
CIK:        0001320414
Form:       8-K
Filed at:   2023-09-07T23:59:59+00:00
Accession:  0001104659-23-098970
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Select Medical names Saich, Mullin Co-Presidents; Malatesta CFO effective Oct 1
-------------------------------------------------------------------------------

- John Saich and Thomas Mullin become Co-Presidents; David Chernow remains CEO. Effective Oct 1, 2023.
- Michael Malatesta appointed CFO; Martin Jackson elevates to SEVP Strategic Finance & Operations.
- Saich (26-year veteran) oversaw Outpatient Rehab; Mullin led Critical Illness Recovery Hospital Operations.
- Other promotions: Tarvin to SEVP General Counsel, Hollenbach to EVP Strategy & Growth, among 12 total.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320414/000110465923098970/0001104659-23-098970-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320414/000110465923098970/tm2325650d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-098970

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer